BPH involves an enlargement of the prostate gland, leading to urethral compression. The incidence of BPH increases with age, affecting approximately 25% of men over 40 years old and about 75% of men over 65 years old symptomatically.
Aquablation is a procedure performed using a robotic system that executes the procedure in an automated manner through a high-velocity, high-pressure water jet with millimeter precision. This water jet is combined with cystoscopy and ultrasound to restore the prostate in a faster, more precise, and safer manner, allowing patients to experience positive results and improvement in urinary symptoms more quickly.
The procedure destroys the prostate tissue compressing and obstructing the urethra, completely relieving the patient's symptoms. This treatment helps preserve sexual function, particularly ejaculation and urinary continence, and is associated with less blood loss.
This surgical procedure is controlled and performed by a robotic system guided by ultrasound and lasts 6 minutes. It is based on two simultaneous images, allowing for a customized plan for each patient and each type and size of the prostate. Once completed, a catheter is placed in the bladder, which is usually removed the next day, and the patient is discharged after 24 hours. Aquablation, operated by the Aquabeam® robotic system, does not use thermal energy, which is advantageous for postoperative recovery.
This is a recent treatment used as an alternative to other more time-consuming techniques with a more complex postoperative course, such as endoscopic, laparoscopic, and laser techniques, which take about 1 hour and 30 minutes.
Aquablation, along with the Focal One® HIFU Robotic System for prostate cancer treatment, micro-ultrasound prostate biopsy, high-definition transrectal prostate micro-ultrasound, and low-intensity shockwave therapy for erectile dysfunction, makes the HPA Urology Group a national reference in this specialty.
.